Exact Mass: 413.0696012
Exact Mass Matches: 413.0696012
Found 90 metabolites which its exact mass value is equals to given mass value 413.0696012,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Desacetylcefotaxime
Desacetylcefotaxime belongs to the family of Cephems. These are organic compounds containing the 5-thia-1-azabicyclo[4.2.0]oct-2-en-8-one nucleus[1]. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
4-(2-Hydroxy-3-(tert-butylamino)propoxy)-3-iodo-1H-indole-2-carbonitrile
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists
5-{2-Fluoro-5-[3-(3-hydroxy-2-methoxycarbonyl-phenoxy)-propenyl]-phenyl}-isoxazole-3-carboxylic acid
Fosdevirine
Glucose lactate glutamate
C14H23NO13 (413.11693479999997)
N-(3-(5-Chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide
C17H14ClF2N3O3S (413.0412428000001)
PLX-4720 is a potent and selective inhibitor of?B-RafV600E?with?IC50?of 13 nM in a cell-free assay, equally potent to c-Raf-1(Y340D and Y341D mutations), and 10-fold selectivity for B-RafV600E than wild-type B-Raf.
3beta-(4-Iodophenyl)tropan-2beta-carboxylic acid isopropyl ester
2-(4-Chlorobenzoyl)-3-({1-methyl-1-oxo-1-[5-(trifluoromethyl)-2-pyridyl]-λ6-sulfanylidene}amino)acrylonitrile
C17H11ClF3N3O2S (413.02125720000004)
R306465
C19H19N5O4S (413.11576940000003)
D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors
(Rp)-1-(1S)-[(2-Diphenylphosphino)ferrocenyl]ethanamine
Cefdaloxime
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Thiazolyl Blue
C18H16BrN5S (413.03097160000004)
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D013778 - Tetrazolium Salts D004396 - Coloring Agents
(2-dimethylaminoethyl)triphenylphosphonium bromide
C22H25BrNP (413.09078800000003)
NU7441(KU-57788)
C25H19NO3S (413.1085584000001)
CJ-42794
C22H17ClFNO4 (413.08300840000004)
[7-(4-nitrooxybutoxy)-4-oxo-2-phenylchromen-5-yl] acetate
C21H19NO8 (413.11106140000004)
FLUORESCENT YELLOW AA223
C20H19N3O5S (413.1045364000001)
Bretylium tosylate
C18H24BrNO3S (413.0660174000001)
C - Cardiovascular system > C01 - Cardiac therapy > C01B - Antiarrhythmics, class i and iii > C01BD - Antiarrhythmics, class iii C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents Bretylium (tosylate) is an inhibitor of the presynaptic release of vasoconstrictor neurotransmitters. It is the sympathetic nerve and adrenergic ganglion blocking agent . (1) Bretylium tosylate inhibits adrenergic function presynaptically only after an initial release in neurotransmitter substance. (2) The reference for administration dose is 15 mg/kg (I.P).
2-(2-(4-BROMOPHENYL)-5,8-DIOXASPIRO[3.4]OCTAN-2-YL)ISOINDOLINE-1,3-DIONE
C20H16BrNO4 (413.02626360000005)
5-[(3,4-dichlorophenyl)azo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-(phenylamino)nicotinonitrile
N-(6-bromo-2,3,4,9-tetrahydro-1H-carbazol-1-yl)-4-nitrobenzamide
C19H16BrN3O3 (413.03749660000005)
3-Chloro-5-[6-chloro-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-yl methyl)phenoxy]benzonitrile
N-(2-aminoethyl)ethane-1,2-diamine,2-(chloromethyl)oxirane,2-cyanoguanidine,sulfuric acid,hydrochloride
C9H25Cl2N7O5S (413.1014860000001)
6-[Difluoro[6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-b]pyridazin-3-yl]methyl]-quinoline hydrochloride
C19H14ClF2N7 (413.09672180000007)
10-Methyl-9-(phenoxycarbonyl)acridinium fluorosulfonate
C21H16FNO5S (413.07331780000004)
(4-cyanobenzyl)triphenylphosphonium chloride
C26H21ClNP (413.1100066000001)
Fosdevirine
C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent
2-(2,6-dichlorobenzyl)-6-phenyl-5-piperidino-3(2H)-pyridazinone
4-Methyl-3-nitrobenzoic acid [6-[[(4-methyl-2-pyrimidinyl)thio]methyl]-4-oxo-3-pyranyl] ester
C19H15N3O6S (413.06815300000005)
5-{2-Fluoro-5-[3-(3-hydroxy-2-methoxycarbonyl-phenoxy)-propenyl]-phenyl}-isoxazole-3-carboxylic acid
3-Diphenol-6-nitro-3H-benzo[DE]isochromen-1-one
C24H15NO6 (413.08993300000003)
4-({4-[(4-Aminobut-2-ynyl)oxy]phenyl}sulfonyl)-N-hydroxy-2,2-dimethylthiomorpholine-3-carboxamide
N(6)-(dimethylallyl)adenosine 5-phosphate(2-)
C15H20N5O7P-2 (413.11003000000005)
15-Demethoxy-epsilon-rhodomycinone
C21H17O9- (413.08725319999996)
[2,3,4,5-Tetrahydroxy-6-(hydroxymethyl)oxan-2-yl] 4-amino-5-(2-hydroxypropanoylperoxy)-5-oxopentanoate
C14H23NO13 (413.11693479999997)
6-[[(2-Ethoxy-1-naphthalenyl)carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
C21H21N2O5S- (413.11711160000004)
5-[(1,3-Benzodioxol-5-ylmethylamino)methylidene]-1-[(4-fluorophenyl)methyl]-2-sulfanylidene-1,3-diazinane-4,6-dione
C20H16FN3O4S (413.08455080000005)
2-[5-(4-hydroxy-3-nitrobenzylidene)-2,4-dioxo-1,3-thiazolidin-3-yl]-N-(3-methylphenyl)acetamide
C19H15N3O6S (413.06815300000005)
N-(4-acetylphenyl)-2-[[1-(3,5-dimethoxyphenyl)-5-tetrazolyl]thio]acetamide
C19H19N5O4S (413.11576940000003)
2-[(4-chlorophenyl)sulfonyl-methylamino]-N-(4-methoxy-2-nitrophenyl)acetamide
5-(4-Bromophenyl)-4-(4-hydroxy-3-methoxyphenyl)-3-methyl-2,4-dihydropyrrolo[3,4-c]pyrazol-6-one
C19H16BrN3O3 (413.03749660000005)
4-hydroxy-N-[[2-oxo-1-(3-oxo-1H-isobenzofuran-1-yl)-3-indolylidene]amino]benzamide
C23H15N3O5 (413.10116600000003)
2-[1-[[4-(4-methoxyphenyl)-1,2,4-triazol-3-yl]sulfanyl]ethyl]-5,6-dimethyl-3H-thieno[2,3-d]pyrimidin-4-one
C19H19N5O2S2 (413.09801139999996)
4-[[(5-Methyl-3-isoxazolyl)amino]methylidene]-2-[3-(trifluoromethyl)phenyl]isoquinoline-1,3-dione
C21H14F3N3O3 (413.09872100000007)
4-[(2E)-2-[1-[4-(Furan-2-ylmethylsulfamoyl)phenyl]ethylidene]hydrazinyl]benzoic acid
C20H19N3O5S (413.1045364000001)
3-Acetyl-4a,6,7,12a-tetrahydroxy-9-methoxy-4,5-dioxo-1,4,4a,5,12,12a-hexahydrotetracen-2-olate
C21H17O9- (413.08725319999996)
methyl 1-(4-chlorophenyl)-5-[(E)-(phenylcarbamothioylhydrazinylidene)methyl]pyrazole-4-carboxylate
C19H16ClN5O2S (413.07131860000004)
6-(2-methoxyphenyl)-3-(2-methylphenyl)-2,5-bis(sulfanylidene)-4H-thiazolo[4,5-d]pyrimidin-7-one
(6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
PLX-4720
C17H14ClF2N3O3S (413.0412428000001)
PLX-4720 is a potent and selective inhibitor of?B-RafV600E?with?IC50?of 13 nM in a cell-free assay, equally potent to c-Raf-1(Y340D and Y341D mutations), and 10-fold selectivity for B-RafV600E than wild-type B-Raf.
4-(2-Hydroxy-3-(tert-butylamino)propoxy)-3-iodo-1H-indole-2-carbonitrile
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists
TAN-1612(1-)
An enolate resulting from the deprotonation of the hydroxy group of the enol moiety of TAN-1612.
(Rac)-NMDAR antagonist 1
C20H20BrN3O2 (413.07388000000003)
(Rac)-NMDAR antagonist 1 is the racemate of NMDAR antagonist 1. NMDAR antagonist 1 is a potent and orally bioavailable NR2B-selective NMDAR antagonist[1].
CBiPES (hydrochloride)
C21H20ClN3O2S (413.09646900000007)
CBiPES hydrochloride is a mGlu2 receptor positive allosteric modulator (EC50: 92.8 nM). CBiPES hydrochloride attenuates stress-induced hyperthermia and PCP-induced hyperlocomotor activity. CBiPES hydrochloride can be used for research of neurological disease[1][2].
LUF6096
LUF6096, a potent allosteric enhancer of the adenosine A3 receptor, is able to allosterically enhance agonist binding. LUF6096 shows low orthosteric affinity for any of the adenosine receptors. LUF6096 shows protective effects in myocardial ischemia/reperfusion injury[1][2].
4-(4-hydroxyphenyl)-12-methyl-1,3-dioxo-2-oxa-7,12-diazatetraphene-8-carboximidic acid
C23H15N3O5 (413.10116600000003)
(e)-[(2e,4z,6e)-4,8-dichloro-3,7-dimethylocta-2,4,6-trien-1-ylidene][(2,3,4,5,6-pentafluorophenyl)methoxy]amine
2-{[hydroxy(4,5,7-trihydroxy-9,10-dioxoanthracen-2-yl)methylidene]amino}-3-methylpentanoic acid
C21H19NO8 (413.11106140000004)
4,5,7-trihydroxy-n-(1-methoxy-3-methyl-1-oxobutan-2-yl)-9,10-dioxoanthracene-2-carboximidic acid
C21H19NO8 (413.11106140000004)
4,5,7-trihydroxy-n-[(2s)-1-methoxy-3-methyl-1-oxobutan-2-yl]-9,10-dioxoanthracene-2-carboximidic acid
C21H19NO8 (413.11106140000004)
5-{2-fluoro-5-[(1e)-3-[3-hydroxy-2-(methoxycarbonyl)phenoxy]prop-1-en-1-yl]phenyl}-1,2-oxazole-3-carboxylic acid
(2s,3s)-2-{[hydroxy(4,5,7-trihydroxy-9,10-dioxoanthracen-2-yl)methylidene]amino}-3-methylpentanoic acid
C21H19NO8 (413.11106140000004)
5-(2-{6-[2-(dimethylamino)ethyl]-2h-1,3-benzodioxol-5-yl}-2-oxoacetyl)-2h-1,3-benzodioxole-4-carboxylic acid
C21H19NO8 (413.11106140000004)
(1s,13s,15s)-7-bromo-12,12-dimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol
methyl 3,4-dimethoxy-2-{5-oxo-2h,7h,8h-[1,3]dioxolo[4,5-g]isoquinoline-6-carbonyl}benzoate
C21H19NO8 (413.11106140000004)